Skip to main content
Be The Investor
S&P 500
7,592.06-0.36%
After Hours7,619.97+0.37%
Nasdaq Composite
25,366.09-0.39%
After Hours25,509.75+0.57%
Dow Jones
52,297.09-0.36%
After Hours52,416.88+0.23%
Russell 2000
2,799.06-1.66%
After Hours2,805.64+0.24%
VIX
VIX
18.70+6.92%
Bitcoin
70,900.58-4.09%
Ethereum
2,009.55-2.15%
Solana
81.32-2.37%
Gold
3,916.70+0.81%
Silver
50.57+1.01%
Copper
6.228+0.66%
WTI Crude Oil
88.21-0.55%
US 10-Year Treasury Yield
5.104+2.12%
Home›Stocks›IAM
OverviewChartNewsFinancialsBusiness ModelCompetitorsStatisticsAnalysisEarningsValuationHoldersOptionsInsidersForecastCompareFAQ

Iambic Therapeutics Inc.

IAM
NASDAQUnited States flagUSReal-Time Price
$14.84USD
-0.55 (-3.54%)Today
$15.10+0.26 (+1.75%)Pre-MarketLast quote · Nov 12, 2026, 8:32 AM ET · Updates paused

Investors Sentoments

Sign in to share your view.

BTI Score

BASIC required or higher

View pricing
BTI Fair Market Cap
$297.70M
Revenue-based (growth phase)
High Risk

Iambic Therapeutics Inc. (IAM) Business Model

How does Iambic Therapeutics Inc. (IAM) make money? A breakdown of revenue segments, margins, competitive moat and the unit economics behind the business.

Error loading business model: Sign in to load this business model